Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)
China flag China · Delayed Price · Currency is CNY
26.84
-0.34 (-1.25%)
At close: Feb 13, 2026

SHE:301206 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
659.66698.51482.71655.821,641772.64
Other Revenue
14.414.416.7919.0933.9310.55
674.06712.9499.5674.911,675783.18
Revenue Growth (YoY)
1.63%42.72%-25.99%-59.71%113.91%64.27%
Cost of Revenue
572.67635.4485.47586.98973.9454.01
Gross Profit
101.3977.5114.0387.92701.42329.17
Selling, General & Admin
34.9425.0520.0520.318.813.96
Research & Development
30.2341.2350.6634.085930.34
Other Operating Expenses
4.52.882.543.217.015.03
Operating Expenses
70.1269.873.3157.3485.1749.27
Operating Income
31.287.71-59.2830.58616.26279.9
Interest Expense
-----0-
Interest & Investment Income
83.9111.41117.1100.343.52.51
Currency Exchange Gain (Loss)
7.457.452.6842.83-7.47-11.35
Other Non Operating Income (Expenses)
-4.93-0.25-0.2-0.27-0.73-0.39
EBT Excluding Unusual Items
117.71126.3160.31173.48611.55270.68
Gain (Loss) on Sale of Investments
---2.89-0.330.26-
Gain (Loss) on Sale of Assets
0.01----0.59-0.35
Asset Writedown
-0.07-0.07--0.21-0.01-2.7
Other Unusual Items
2.581.961.411.028.682.52
Pretax Income
120.23128.258.82183.96619.9270.14
Income Tax Expense
2923.252.8420.2784.4837.57
Net Income
91.34104.9555.98163.69535.42232.57
Net Income to Common
91.34104.9555.98163.69535.42232.57
Net Income Growth
-4.17%87.47%-65.80%-69.43%130.21%70.62%
Shares Outstanding (Basic)
199202200200152152
Shares Outstanding (Diluted)
199202200200152152
Shares Change (YoY)
-2.16%0.95%0.16%31.61%-0.00%3.86%
EPS (Basic)
0.460.520.280.823.531.53
EPS (Diluted)
0.460.520.280.823.531.53
EPS Growth
-2.06%85.71%-65.85%-76.77%130.22%64.29%
Free Cash Flow
-161.39-155.41-65.68-158.4207.765.6
Free Cash Flow Per Share
-0.81-0.77-0.33-0.791.370.43
Dividend Per Share
1.5001.4000.2500.7000.6670.467
Dividend Growth
130.77%460.00%-64.29%5.00%42.85%-
Gross Margin
15.04%10.87%2.81%13.03%41.87%42.03%
Operating Margin
4.64%1.08%-11.87%4.53%36.78%35.74%
Profit Margin
13.55%14.72%11.21%24.25%31.96%29.70%
Free Cash Flow Margin
-23.94%-21.80%-13.15%-23.47%12.40%8.38%
EBITDA
102.4473.920.3269.33641.9296.79
EBITDA Margin
15.20%10.37%0.07%10.27%38.31%37.90%
D&A For EBITDA
71.1766.2159.6138.7525.6516.89
EBIT
31.287.71-59.2830.58616.26279.9
EBIT Margin
4.64%1.08%-11.87%4.53%36.78%35.74%
Effective Tax Rate
24.12%18.14%4.82%11.02%13.63%13.91%
Revenue as Reported
674.06712.9499.5674.911,675783.18
Advertising Expenses
-1.261.170.721.080.73
Source: S&P Global Market Intelligence. Standard template. Financial Sources.